TLIF yields 41666.67% · JNJ yields 2.13%● Live data
📍 TLIF pulled ahead of the other in Year 1
Combined, TLIF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TLIF + JNJ for your $10,000?
TOCCA Life Holdings, Inc. operates sober living facilities in Lake Worth, Lantana, and Boynton Beach, Florida. The company provides clinical toxicology testing services to monitor the illicit drug use and transforms sobriety addicted clients and the community into productive members of society. It offers sober support services; operates an addiction treatment center; provides sober life coaching and transitional living programs; conducts sports events and fitness activities; and operates house recovery residence facilities and sober living recovery residences. It offers equipment, materials, and demonstrations in the areas of cooking, cleaning, household maintenance, business etiquette, basic math, basic banking, computer skills, writing skills, life coaching, transitional living management, graphic art, information technology, marketing, television production, interest rate theories, credit cost valuation, mortgage banking, career opportunities, business models, business infrastructures, business ethics, and entrepreneurship. It also offers prepaid services, which include hygiene, linen, grocery, and other products and services online. The company was formerly known as TOCCA Life Coaching, Inc. and changed its name to TOCCA Life Holdings, Inc. in January 2015. TOCCA Life Holdings, Inc. was founded in 2013 and is based in Lake Worth, Florida.
Full TLIF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.